July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
A Novel Decorin and SAHA Combination Therapy to Treat Bleb Fibrosis in Vivo in Rabbits
Author Affiliations & Notes
  • Jella Angela An
    Mason Eye Institute, University of Missouri, School of Medicine, Columbia, Missouri, United States
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
  • Suneel Gupta
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
    Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri, United States
  • Michael K Fink
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
    Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri, United States
  • Nathan Hesemann
    Mason Eye Institute, University of Missouri, School of Medicine, Columbia, Missouri, United States
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
  • Ratnakar Tripathi
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
    Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri, United States
  • Prashant R Sinha
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
    Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri, United States
  • Lindsey McDaniel
    Mason Eye Institute, University of Missouri, School of Medicine, Columbia, Missouri, United States
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
  • Rajiv R Mohan
    Ophthalmology, Harry S. Truman Memorial Veteran Hospital, Columbia, Missouri, United States
    Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri, United States
  • Footnotes
    Commercial Relationships   Jella An, None; Suneel Gupta, None; Michael Fink, None; Nathan Hesemann, None; Ratnakar Tripathi, None; Prashant Sinha, None; Lindsey McDaniel, None; Rajiv Mohan, None
  • Footnotes
    Support  MAPS grant and Young Clinician-Scientist Awards from American Glaucoma Society (JA), Ruth M. Kraeuchi Missouri Endowed Chair Ophthalmology Fund (RRM), and partial support from the NIH/NEI R01EY017294 (RRM) and Veterans Health Affairs 1I01BX00357 (RRM) grants
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 474. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jella Angela An, Suneel Gupta, Michael K Fink, Nathan Hesemann, Ratnakar Tripathi, Prashant R Sinha, Lindsey McDaniel, Rajiv R Mohan; A Novel Decorin and SAHA Combination Therapy to Treat Bleb Fibrosis in Vivo in Rabbits. Invest. Ophthalmol. Vis. Sci. 2018;59(9):474.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Successful glaucoma filtration surgery (GFS) requires incomplete healing of scleral wound and complete healing of epithelial and conjunctival wound. Mitomycin-C (MMC), current standard-of-care antifibrotic agent, can lead to nonspecific tissue toxicity and raise the risk of sight-threatening complications. This study evaluated therapeutic potential of AAV-decorin (DCN) and SAHA combination therapy to safely and effectively modulate tissue-specific ocular fibrosis after GFS using an in vivo rabbit model.

Methods : Thirty New Zealand White rabbits were divided into 5 groups: No GFS (surgery-naïve control), GFS +BSS (negative control), GFS +MMC (positive control), GFS +AAV-DCN (test-1), and GFS +AAV-DCN +SAHA (test-2). A fornix-based trabeculectomy was performed by one surgeon. BSS, MMC and AAV-DCN were administered by subconjunctival injection pre-operatively, and SAHA was administered topically BID for 5 days post-operatively. Slit-lamp exams, tonometry, corneal pachymetry and confocal microscopy were performed pre-operatively and on post-operative day-1, -3, -7, -14 and -21. Stereomicroscope was used to measure bleb size and vascularity. Ocular tissues were collected on day-7 and -21 to be snap frozen and subjected to gene expression and protein analyses using qRT-PCR, H&E, immunofluorescence and/or western blotting.

Results : Pre-operatively, all 5 groups had similar clinical findings including intraocular pressure (IOP), pachymetry, endothelial cell counts (ECC) and appearance of ocular surface. By postoperative day-3, complete scleral fibrosis, conjunctival hyperemia and flattening of filtering bleb was seen in BSS group, and cystic thin bleb with poor conjunctival and corneal epithelial healing was seen in MMC group. Lack of scleral fibrosis while maintaining complete conjunctival and corneal wound healing was seen in both AAV-DCN and AAV-DCN +SAHA groups, although early hyperencapsulation was evident on day-21 in AAV-DCN group only. IOP, pachymetry and ECC remained physiologic and stable in all 5 groups postoperatively, and there were no sight-threatening complications, including bleb leak, hypotony, retinal detachment and endophthalmitis. The results of H&E, qRT-PCR and immunofluorescence are pending and will be reported at the meeting.

Conclusions : AAV-DCN and SAHA combination therapy has potential to improve outcome of GFS by inhibiting scleral fibrosis without surrounding tissue toxicity.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×